申请人:Baldwin Amy
公开号:US20120208204A1
公开(公告)日:2012-08-16
The invention provides methods and compositions for inhibiting p53-inactivated cancers. Cancer cells are preferentially inhibited compared to normal cells by inhibiting tumor survival kinases that are required for growth of tumor cells but not normal cells.